Life sciences news
-
Sequana Medical announces DSMB approval to start randomized MOJAVE cohort – US Phase 1/2a study of DSR® 2.0 for treatment of heart failure
Tuesday January 23rd 2024
Read more
-
argenx announces approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) injection for subcutaneous use in Japan for generalized myasthenia gravis
Wednesday January 17th 2024
Read more
-
QbD Chair for Precision Oncology Research in Glioblastoma extended for three years
Wednesday January 17th 2024
Read more
-
KU Leuven researchers discover how to break the negative feedback loop to improve cancer immunotherapy
Tuesday January 16th 2024
Read more
-
Health & care incubator BioVille strengthens its position with additional 2,000m² wing
Tuesday January 16th 2024
Read more
-
Aphea.Bio welcomes Hadyn Parry as Chairman of its Board: propelling the company's vision for sustainable agriculture
Wednesday January 10th 2024
Read more
-
Researchers map cell composition of metastatic melanoma and identify cause of immunotherapy resistance
Tuesday January 9th 2024
Read more
-
From goblet cells to gut health: the role of AGR2 and mucus
Monday January 8th 2024
Read more
-
Become a flanders.bio member
Your news here?
-
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
Friday January 5th 2024
Read more
-
Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncology
Thursday January 4th 2024
Read more
-
Sequana Medical granted US CPT® III reimbursement codes for alfapump® system
Wednesday January 3rd 2024
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
